Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma-Reference-Cited by-同舟云学术

Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma

Published:2020-02-14 Issue:4 Volume:34 Page:484-494
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Fontanilles Maxime¹²³^ORCID,Fontanilles Adeline⁴,Massy Nathalie³,Rouvet Jean⁵,Pereira Tony³,Alexandru Cristina²,Hanzen Chantal⁶,Basuyau Florence⁵,Langlois Olivier⁷,Clatot Florian¹²,Tennevet Isabelle²,Di Fiore Frédéric¹²⁸,Joannidès Robinson³⁹,Lamoureux Fabien³⁹

Affiliation:

1. UNIROUEN Inserm U1245 IRON group Institute for Research and Innovation in Biomedicine Normandy Centre for Genomic and Personalized Medicine Rouen University HospitalNormandie Univ F-76031Rouen France

2. Department of Medical Oncology Cancer Centre Henri Becquerel F‐76000Rouen France

3. Department of Pharmacology Rouen University Hospital F‐76031Rouen France

4. Institut supérieur d'agriculture Rhône‐Alpes ISARA‐Lyon F‐69007Lyon France

5. Department of Pharmacy Cancer Centre Henri Becquerel F‐76000Rouen France

6. Department of Radiation Oncology and Medical Physics Cancer Centre Henri Becquerel F‐76000Rouen France

7. Department of Neurosurgery Rouen University Hospital F‐76031Rouen France

8. Department of Hepatogastroenterology Rouen University Hospital F‐76031Rouen France

9. UNIROUEN Inserm U1096 Institute for Research and Innovation in Biomedicine Rouen University Hospital Normandie Univ F-76031Rouen France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12539

Reference37 articles.

1. The epidemiology of glioma in adults: a "state of the science" review

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

4. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

5. Newly diagnosed glioblastoma: a review on clinical management;Lukas R.V.;Oncology (Williston Park, NY).,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta;Neuro-Oncology Practice;2023-10-27

2. Temozolomide;Reactions Weekly;2020-08